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Bone Marrow-Derived Cell Concentrates Have Limited
Effects on Osteochondral Reconstructions in the Mini Pig
Michael Jagodzinski, MD, PhD,1 Chaoxu Liu, MD,2 Daniel Guenther, MD,1 Arne Burssens, (med. student),3
Maximilian Petri, MD,1 Reza Abedian, MSc,4 Elmar Willbold, MSc,4 Christian Krettek, MD, PhD,1
Carl Haasper, MSc, MD, PhD,5,* and Frank Witte, PhD4,*
This study investigates the effects of seeding a chondrogenic and osteogenic scaffold with a bone marrow-
derived cell concentrate (BMCC) and reports the histological and mechanical properties 3 months after im-
plantation in the miniature pig. Twenty defects (7 · 10mm) were created in the femoral condyles of 10 miniature
pigs. The defects were left empty (E), filled with the grafted cylinder upside down (U) or with a combined
scaffold (S) containing a spongious bone cylinder (Tutobone) covered with a collagen membrane (Chon-
drogide). In a fourth group, the same scaffolds were implanted but seeded with a stem cell concentrate (S+
BMCC). The animals were stained with calcein green after 2 weeks and xylenol orange after 4 weeks. After 3
months, the animals were sacrificed, and a mechanical analysis (Young’s modulus), macroscopic, and histologic
(ICRS Score) examination of the specimens was conducted. Young’s modulus in the periphery was significantly
lower for group E (67.5 – 15.3 kPa) compared with untreated controls (171.7 – 21.6 kPa, p < 0.04). Bone defects
were smaller in group S (10% – 8%) compared with E (27% – 7%; p < 0.05). There was a trend toward smaller
bony defects on comparing groups E and S + BMCC (11% – 8%; p = 0.07). More red fluorescence was detected in
group S + BMCC (2.3% – 1.1%) compared with groups E (0.4% – 0.2%) and U (0.5% – 0.2%, p < 0.03). ICRS scores
were higher for groups S (25.3 – 3.8) and S + BMCC (26.2 – 5.2, p < 0.01). In this animal model of osteochondral
defects, stem cell concentrates enhance new bone apposition but fail to improve mechanical properties or
histological appearance of cartilage regenerates in critical-sized defects.
Introduction
Osteochondral defects can be caused by trauma, tu-mor, infection, and intrinsic pathologies such as os-
teochondrosis dissecans.1 Successful treatment remains a
challenge for the orthopedic community, and autologous
osteochondral transplants remain the gold standard.1 Nu-
merous alternatives have been reported, including organic
and synthetic biomaterials.2 Even though these materials
show promising results during in-vitro investigations, prob-
lems regarding the substitution with vascularized bone re-
main an obstacle for widespread clinical use in large defects.3
A potential solution is the implantation of autologous bone
marrow-derived cells either after in-vitro expansion4 or after
concentration in a single-stage procedure.5 However, there is
limited information about the efficacy, as controls are miss-
ing in most clinical studies.5,6 The effect of stem cell con-
centrates in the cartilage defect of horses is limited to
improved regenerate size and histological appearance.7
Most recent studies have demonstrated benefits of cell
seeding on histological and mechanical properties of os-
teochondral reconstructions.8,9 Other groups could not detect
the mechanical superiority of cell-seeded constructs com-
pared with empty scaffolds.10 Irrespective of whether cells
are used or not, reconstruction of the subchondral bone re-
mains the key element to osteochondral reconstruction.11
In animal experiments, the mini pig has been frequently
used to investigate osteochondral defects, as it is known
that empty defects of 6 · 10mm or beyond cause incom-
plete defect regeneration within 2 years.12,13 Different bio-
materials have been implanted in these defects with or
without cells.10,14 In contrast to isolated bone defects,
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autologous cell-seeded constructs do not improve the histo-
logical appearance of the regenerates.10
For the evaluation of osteochondral reconstructions, histo-
logic and mechanical examination protocols are suggested.15
Mechanical properties of healthy cartilage and cartilage re-
generates have been thoroughly investigated.16,17 The use of
equilibrium modulus by creep indentation testing has been
used in several animal models, including the mini pig.10
Histological semi-quantitative scores of osteochondral re-
generates have been used within several species to elucidate
the effects of osteochondral reconstruction using various
biomaterials.10,18
The purpose of this study is to investigate the advantage of
seeding a composite osteochondral scaffold with an autolo-
gous stem cell concentrate by comparing the histologic and
mechanic properties in the mini pig. The hypothesis is that
cell-seeded constructs demonstrate equal mechanical and
histologic properties as unseeded constructs or controls with
empty defects or upside-down implanted bone cylinders.
Materials and Methods
Experimental design
All operations and handling procedures were approved
by the local district veterinary administration and complied
with the animal protection act. A total of 11 skeletally mature
Go¨ttingen miniature pigs of female sex were used (manufac-
turer: Education and Research Institute Ruthe of the Uni-
versity of Veterinary Medicine Hannover, Foundation,
Sarstedt, Germany). The mean age was 14 months, and the
mean weight was 58.3– 6.7 kg. All animals received a unilat-
eral arthrotomy of the right knee joint. In each knee, two de-
fects (width: 7mm, depth: 10mm) were created by an
osteochondral articular transplant system (OATS, Arthrex,
Naples, Florida) in the weight-bearing area of the medial or
lateral femoral condyles. A total of 20 defects were analyzed.
The defects were assigned to one of the following groups by a
computer-generated random list: In group E, the defects were
left empty. In group U, the cartilage of the osteochondral
cylinders was removed, and the cylinder was reimplanted in
the defect upside down. In group S, a xenogenic conical bone
cylinder with a minimum diameter of 7mm and a maximum
diameter of 8mm, a height of 9mm (bovine origin, Tuto-
bone, Tutogen Medical, Neunkirchen a. Br., Germany) was
impacted into the defect. When the surface of the cylinder was
flush with the joint surface, a Luer instrument was used to
adjust the surface to the articular concave shape. Then, a
plunger was used to insert the cylinder further until it came to
rest flush with the subchondral bone. An 8mm-diameter os-
teoarticular transplant system (OATS. Arthrex) instrument
was used to trim a collagen I/III scaffold (Chondrogide,
Geistlich Pharma, Wolhusen, Switzerland) to a round-shaped
patch. The patch was put on the defect and secured by seven
sutures using a non absorbable polypropylene (Prolene 7-0,
Ethicon, Johnson&Johnson, Norderstedt, Germany) suture. In
group scaffold (S)+ bone marrow-derived cell concentrate
(BMCC), the animals received a bone marrow aspiration on
the left posterior iliac crest. A Jamshidi aspiration syringe was
positioned on the dorsal aspect of the posterior iliac crest and
advanced into the intramedullary cavity. After an injection of
2.000 IE heparine, an aspiration and concentration system
(Marrowstim, Biomed, Warsaw, IN) was used according to
the guidelines of the manufacturer.19,20 Briefly, 20mL of bone
marrow aspirate were used to create 3mL of concentrate. The
concentrate was transferred in a custom-made cell-seeding
device (manufactured by the Institutional Central Research
Laboratories of Hannover Medical School (MHH); Fig. 1). The
chamber underneath the scaffolds was filled with a dialysis
and replacement solution (Gambro Dasco SpA, Medolla, Ita-
ly),21 and it consisted of Na+ 117mM, Mg+ + 0.70mM, and
Cl-117mM. After 20min, the chamber was opened, and the
scaffolds were transferred into the sterile field. The bone
scaffold was advanced into the defect with a pusher. After
contouring the surface 2mm before the final position with a
Luer instrument, the cylinders were advanced until the sur-
face of the implants was in line with the subchondral bone. At
this point, the cell-seeded membrane was attached with the
cell-loaded side facing the implant and attached by 6–7 pro-
lene sutures (size: 7-0 USP; Johnson and Johnson Medical,
Brunswick, NJ; Fig. 2). After irrigation, the patella was re-
attached to the retinaculum with a Mersilene size 0 suture and
the joints were closed with a PDS size 2-0 suture. Skin closure
was achieved with staples.
The animals were allowed to move freely and were weight
bearing as tolerated under analgesia with Ibuprofene
(10mg/kg of body weight/day) for 7–10 days. They were
daily monitored for pain, distress, and discomfort and the
lameness was scored weekly according to Winkler and
Willen.22 The weight and temperature were protocolled
twice per week. After 2 weeks, a subcutaneous injection of
Calcein green (Sigma Aldrich Chemical, Taufkirchen, Ger-
many) with 10mg/kg of body weight was administered,
followed by another subcutaneous administration of Xylenol
orange tetrasodium (Sigma Aldrich Chemical; 100mg/kg of
body weight) after 4 weeks.
Three months after the operation, the animals were sac-
rificed, and all soft tissue was removed from the knee joint.
Bone marrow analysis
In order to provide an idea of how many progenitor cells
were transplanted, the number of fibroblast colony-forming
units (CFU-F) were determined. Although the observed cell
colonies were not identified by FACS analysis, the CFU-F has
been used before to report the bone marrow characteristics.6
The number of cells was counted within 1mL of aspirate and
concentrate using a hemocytometer (Sysmex SE-5000 Auto-
mated Hematology Analyzer, TOA Medical Electronics,
Kobe, Japan). Cells were washed once and resuspended in
culture media (DMEM/Ham’s F-12 1:1; Biochrom, Berlin,
Germany). Density centrifugation was used to obtain a cell
pellet that was resuspended in the culture media mentioned
earlier supplemented with 10% fetal calf serum, 200U/mL
Penicillin/Streptomycin (Gibco, Karlsruhe, Germany), 2.5mg/
mL Amphotericin B (Biochrom), supplemented with FGF-2
(3ng/mL; Pepro Tech, Offenbach, Germany) buffered with
HEPES buffer (Roth, Karlsruhe, Germany; pH 7.0), and, sub-
sequently, plated in 75 cm2 culture flasks (Nunc, Berlin, Ger-
many) and incubated at 37C and 5% CO2 in a humidified
atmosphere. The medium was changed every 3 days. In a
previous study with the same culture media,23 the fibroblast
nature of these cells has been demonstrated using antibodies
for collagen I and III and by the up-regulation of tenascin-C.
Fibroblast colonies were Giemsa stained and counted using an
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inverted light microscope at 25·magnification. Any aggre-
gate with at least 50 cells was scored as one colony. The results
were expressed as CFU-F per 106 bone marrow cells.
Macroscopic analysis
The regenerated cartilage was examined using the Inter-
national Cartilage Society (ICRS) Macroscopic Score, which
determines the degree of defect repair, integration to the
border zone, and the macroscopic appearance24 (Appendix
Table A1). The scoring was done by a blinded investigator
from the own Institute (C. L.) and by a blinded, independent
observer from a different Institution (A. B.) with assistance of
an experienced pathologist (R. F.).
Mechanical characterization
For mechanical characterization, the specimens were tes-
ted under creep indentation.17,25 A custom-built creep in-
dentation machine [manufactured by the Institutional
Central Research Laboratories of Hannover Medical School
(MHH)] featuring a flat-end cylindrical indenter of 1.0mm
diameter was used to apply a force of 0.1N until a steady-
state maximum indentation depth was achieved (Fig. 3). The
10mm-high cylindrical specimens containing the defect re-
gion and peripheral healthy articular cartilage with the un-
derlying cortical and trabecular bone tissue were obtained
using 6mm-diameter tissue punches. The specimens were
glued perpendicular to the dish floor. Then, the dish was
filled with phosphate-bufferd saline (PBS) until it wet the
specimen’s upper surface. Three locations were measured in
both the defect and healthy cartilage regions The graphical
user interface to operate the test was programmed with
LabVIEW 6.1 (National Instruments, Austin, TX). Creep
indentation was first performed, followed by a needle-probe
thickness measurement at the identical location;26 all tests
were performed at 37C in 0.15M PBS solution. An analytical
solution was then applied to derive the Young’s modulus
assuming the Poisson’s ratio of 0.42.
FIG. 1. (A–G) Schematic (A) showing the custom-made device that was used in order to transfer the stem cell concentrate
onto the porous bone scaffold and the collagen membrane which was placed underneath (D, E, white arrow). (1) Stem cell
concentrate. (2) porous bone scaffold (Tutobone, Tutogen Medical, Neunkirchen a. Br., Germany). (3) Collagen scaffold (Chon-
drogide, Geistlich Biomaterials, Wolhusen, Switzerland). (4) Hyperosmolaric solution consisting of Na+ 117mM, Mg+ + 0.70mM,
and Cl-117mM (Gambro Dasco SpA, Medolla, Italy).21 The buffy coat (B, arrow) was withdrawn from the system (Marrowstim,
Biomet, Washaw, IN) and transferred onto the scaffolds (C, arrow: drop of stem cell concentrate). Confocal laser light microscopy
was used in order to visualize the distribution of the cells on the collagen membrane (F, G, bar represents 150mm). Color images
available online at www.liebertpub.com/tec
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Histology and histomorphometry
The regenerates were split in the longitudinal plane using
a micro saw (Martor, Solingen, Germany). Then, cylinders
with 8mm diameter and 10mm depth were harvested using
an osteoarticular transplantation system (OATS, Arthrex,
Fig. 3A). Care was taken to ensure the integrity of the other
half cylinder. With a 14mm-diameter OATS instrument, a
half cylinder was detached and stored in a 4% paraformal-
dehyde solution in PBS for 7 days. The samples were em-
bedded in Technovit 9100 New1 (Heraeus-Kulzer, Hanau,
Germany) according to the manufacturer’s guidelines. 5mm
thin sections were cut using an RM2155 microtome (Leica,
Bensheim, Germany) and adhered onto silane-coated slides.
Photomicrographs were recorded with a Zeiss Axioskop 40
microscope equipped with a Zeiss AxioCam Mrc digital
camera and Zeiss AxioVision software (Zeiss, Oberkochen,
Germany).
Collagen II
For collagen II immunohistochemistry, sections were pre-
pared with Xylol, monoethanolamine (MEA), and a series
of diluted isopropanol/ethanol. Endogenous peroxidases
were removed by treatment with 0.3% H2O2/PBS for 30min.
Sections were blocked for 30min with phosphate-buffered
saline-0.05% Tween20 (PBST) containing 10% goat serum
(PBST-S). The sections were incubated with rabbit monoclonal
collagen II antibody (Acris Antibodies, Herford, Germany) for
60min at room temperature. The primary antibodies were di-
luted to 1:200 with PBS. Sections were washed twice with PBST
and then incubated with the secondary antibody (Vectastain
ABC Kit; Vector Laboratories, Burlingame, CA) for 30min.
Counterstaining was achieved using Harris hemalaun solution
for 3min. Sections were mounted with Aquatex (Merck,
Darmstadt, Germany). The negative control was prepared with
PBST instead of the primary antibody. The ICRS Visual His-
tological Assessment Scale24 was used for a semiquantitive
analysis of the histological findings (Appendix Table A1).
Quantification of fluorochrome positive/defect areas
Quantification of fluorescence positive areas was per-
formed using SigmaScan software. A region of interest was
set to an area with a width of 6mm and a height of 8mm
(Fig. 5D), and the fluorescence positive and defect areas are
reported as a percentage of the entire area.
Tartrate-resistant acid phosphatase
Tartrate-resistant acid phosphatase (TRAP) is a glycosy-
lated monomeric metalloenzyme that is highly expressed in
FIG. 2. (A–D)Groups investigated in this study: 20 7mm-wide and 10mm-deep osteochondral lesionswere created in theweight-
bearing zone of the medial and lateral femoral condyles of skelettaly mature Goettinger miniature pigs. The animals were randomly
assigned to one of the following groups: Empty defect (A, group E), upside-down cylinder after complete removal of the articular
cartilage (C, group U), a spongiosa cylinder from xenogenic origin (Tutobone) covered with a collagen membrane (Chondrogide)
attachedby circumferential sutures (B, group S), and the same construct but cell loadedwith bonemarrow-derived concentrated cells
(D, group scaffold [S]+bone marrow-derived cell concentrate [BMCC]). Color images available online at www.liebertpub.com/tec
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osteoclasts, activated macrophages, and neurons.27 TRAP
staining was carried out using a manufacturer’s protocol
(387A-1KT; Sigma Aldrich, Inc., St. Louis, MO). The number
of TRAP-positive cells was determined within an area of
8x6mm around the center of the defect (Figs. 6D and 7).
Statistical analysis
Numerical data are reported using mean values and
standard deviation (SD), such as range. Variables were an-
alyzed using analysis of variance followed by Bonferroni’s
correction for multiple comparisons. Statistical significance
was predetermined using a p-value of < 0.05. The inter-
observer reliability was investigated and is reported as k
with a corresponding confidence interval. All statistical tests
were computed using SPSS for Macintosh (version 20.0; IBM
SPSS Statistics Corp., New York, NY).
Results
There were no wound complications, but two patella
dislocations had occurred at final follow up. One animal was
unable to walk after 5 days and was euthanized before fin-
ishing the study period. It was replaced by another animal
receiving the same treatment after receiving consent from the
local district veterinary administration. Lameness of the an-
imals gradually improved, and the gait score according to
Winckler and Willen22 at final follow up was 3.8 – 1.4 (1–5)
with no significant differences between the groups ( p= 0.95).
Bone marrow characteristics
In order to assess the number of cells that were trans-
planted, bone marrow characteristics were analyzed: An av-
erage of 3.1– 0.1mL (2.9–3.3mL) of bone marrow aspirate was
concentrated using the Marrowstim system. The number of
nucleated cells counted within the aspirates ranged from 6.5 to
13.4 million/mL, with a mean of 10.7– 2.6 million/mL. The
mean number of CFU-F per one million nucleated cells ob-
tained from the samples ranged from 30 to 60, with a mean of
46.0– 11.0. The characteristics of the concentrates are reported
in Table 1. Directly after seeding, the efficacy of the transfer of
cells was visualized by Laser microscopy (Fig. 1F, G).
Mechanical properties
As a measure of the stiffness of the osteochondral recon-
structions, Young’s modulus was investigated. Young’s
modulus in the center of the defects was determined with
37.3 – 22.6 kPa (20–69 kPa) for group E, 57.8 – 16.9 kPa (44–
82 kPa) for group U, 44.4 – 21.9 kPa (27–79 kPa) for group S,
and 61.2 – 38.3 kPa (11–114 kPa) for group S + BMCC. There
was a significant difference in Young’s modulus between all
experimental groups and the controls ( p < 0.01; Fig. 3C).
FIG. 3. (A–D) Immediately after sacrifice, the femora were harvested, and a 6mm cylinder was withdrawn containing both
the defect with a central portion and adjacent healthy cartilage (A). Creep indentation testing (B) was performed in two
locations of the center (A 4, 5) and three locations of the periphery of the defects (A 1–3). Young’s modulus of healthy
cartilage (controls) was significantly higher than all other central groups (C, asterisk, p < 0.01) and higher than empty defects
in the periphery (D, asterisk, p< 0.04). Color images available online at www.liebertpub.com/tec
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Young’s modulus in the periphery of the defects was de-
termined with 67.5 – 15.3 kPa (range: 50–87 kPa) for group E,
117.0– 56.8 kPa (64–194 kPa) for group U, 112.6 – 56.8 kPa
(44–197 kPa) for group S, 131.2– 41.2 kPa (94–194 kPa) for
group S +BMCC, and 171.7– 21.6 kPa (144–190 kPa) for the
surrounding untreated cartilage. There was a significant
difference in Young’s modulus between group E and the
controls ( p< 0.04; Fig. 3D).
Defect healing and evaluation
The regenerates were evaluated and scored by two inde-
pendent observers macroscopically and histologically: Most of
the empty defects (4/5) healed with a remaining fibrous cyst
without trabecular bone (Fig. 4A, B). There was a gradual
change from central fibrous tissue to fibrocartilage in 3 out of 5
specimens and no transition zone into the surrounding heal-
thy hyaline cartilage (Fig. 4C). Macroscopic morphology of the
regenerates was more diverse in the group with the upside-
down cylinders. A remaining bone defect was found in 3 out
of 5 animals. Hyaline cartilage formation was found on the
overgrowing edges of the defect (Fig. 4D). In both groups S
and S+BMCC, 4 out of 5 defects healed with reconstruction of
the underlying subchondral bone plate. There was a transition
zone from the regenerate with varying amounts of fi-
brocartilage into the surrounding hyaline cartilage (Fig. 4D).
The intraclass correlation coefficient was 0.81 (0.56 to 0.92)
for the detection of the total defect area, 0.89 (0.84 to 0.98) for
the measurements of red fluorescence, and 0.84 (0.63 to 0.94)
for green fluorescence between both observers. Due to the
high level of agreement, mean values of both observers were
used for further analysis.
The area of defect was calculated with 27%–7% (21–34%) for
group E, 24%–9% (16–35%) for group U, 10%–8% (0–19%) for
group S, and 11%–8% for group S+BMCC. There was a sig-
nificant difference between the groups (p<0.02). Subgroup
analysis showed that there were less bone defects on comparing
group E with S (p<0.05) and a trend toward less defect area on
comparing groups E and S+BMCC (p=0.07, Fig. 5A).
The amount of red fluorescence staining was 0.4% – 0.2%
(0.08–0.57%) in group E, 0.5% – 0.2% (0.3–0.7%) for group U,
1.2% – 1.0% (0.3–2.4%) for group S, and 2.3% – 1.1% (1.2–
3.3%) for group S +BMCC (significantly higher than in
groups E, U, p< 0.03, Fig. 5B, D).
FIG. 4. (A–D)Representativemacroscopic appearance of the defects (A) after harvesting.Microscopic appearance in the Saftranin-
O/vonKossa stain (B,magnification 2.5· , bar represents 2mm).More defects showed cyst formations in groupswith emptydefects
and upside-down cylinders.Magnification of the interzone between the defect and surrounding cartilage (C): It was sharply defined
in the empty and upside-down cylinder group; in contrast, a transitional interzone was found in groups treated with scaffolds
and scaffolds seededwith stem-cell concentrates (S andS+BMCC; bar represents 1mm). The appearancewas confirmedby collagen
II immunostaining and negative stained controls (D). Color images available online at www.liebertpub.com/tec
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The amount of green fluorescence staining was 0.4%– 0.1%
(0.25–0.55%) in group E, 1.2– 0.5 (0.8–1.9%) for group U,
1.9%– 0.8% (0.7–2.6%) for group S, and 2.2%– 0.9% (1.2–3.3%)
for group S+BMCC. There was a significant difference be-
tween the groups ( p= 0.01). Subgroup analysis demonstrated
a lower amount of green fluorescence in group E compared
with both S ( p< 0.05) and S+BMCC ( p<0.02; Fig. 5C, D).
ICRS and TRAP evaluation
The inter-reader k for both macroscopic and microscopic
ICRS scores was 0.68, which is interpreted as ‘‘substantial
agreement’’ according to Landis and Koch Appendix Table
A2, Spearman correlation: 0.91 for microscopic and 0.93 for
macroscopic analysis, p < 0.01). Therefore, the mean values of
both observers were used for the exploration of the data.
Microscopic ICRS scores were 4.1 – 1.2 (2.5–5.0) for group E,
6.8 – 1.2(6.0–8.5) for group U, 8.6 – 0.9 (6.5–10.0) for group S,
and 8.5 – 2.2(6–11) for group S +BMCC ( p < 0.01). Macro-
scopic ICRS scores were 3.4 – 0.9 (2.5–4.5) for group E,
6.4 – 2.1 (4.5–9.0) for group U, 8.3 – 1.4(6.5–10.0) for group S,
and 8.7 – 1.3(8–10.5) for group S+BMCC ( p < 0.01). There
was no significant difference in the overall assessment.
However, the ICRS total scores were 13.0 – 3.2 (10.0–16.0) for
group E, 19.4 – 4.0 (15.5–25.0) for group U, 25.3 – 3.8 (19.0–
28.5) for group S, and 26.2 – 5.2(18.0–31.0) for group S +
BMCC ( p< 0.01). The scores of group E were significantly
lower than those of groups S, S +BMCC ( p< 0.01; Fig. 6A–C).
FIG. 5. (A–D)Graphs representing the area of bony defect onmicroscopic evaluation (A), red and green fluorescence caused by
the detection of calcein green and xylenol orange administered subcutaneously after 2 and 4 weeks. (B, C, representative images
inD). There was significantly more bone defect visible after 3 months in the empty group compared with the group treated with
scaffolds alone (asterisk, p< 0.05) and a trend toward a less defect area on comparing empty groups with scaffold and stem-
cell-concentrate treated groups ( p= 0.07). More red fluorescence was detected in group scaffold+BMCC compared with the
empty group and upside-down cylinders (B, asterisk, p< 0.03). Less green fluorescence was found in empty defects compared
with group scaffold and scaffold+BMCC (C, asterisk, p< 0.05). Color images available online at www.liebertpub.com/tec
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The number of osteoclasts was found to be 87.8 – 63.0 in
group E, 69.3 – 29.1 in group U, 60.0 – 36.8 in group S, and
47.6 – 31.9 in group S +BMCC. There was no significant dif-
ference between the groups ( p = 0.53). Representative sec-
tions of the defects are displayed in Figure 6D.
Discussion
This study showed that in miniature pigs the healing of
osteochondral defects was enhanced in the presence of po-
rous bone scaffolds covered with a collagen membrane. The
addition of a bone marrow aspirate concentrate had only a
limited benefit on bone synthesis within the scaffold. This is
remarkable, as other studies using different cell types such as
chondrocytes, osteocytes, adipose-derived stem cells, mes-
enchymal stem cells (MSCs), transgenic cells, or platelet-rich
plasma28–30,33 showed significant benefits for the regenera-
tion of meniscus,4 cartilage,31 or bone.32,33 Although it seems
that the efficacy of regeneration supporting cells or bioactive
molecules is not present in all cases, the benefits of porous
scaffolds for stabilizing the defects and for providing a sim-
ple matrix for ingrowing cells are repeatedly reported.33–35
Obviously, the material the scaffolds are made of plays
only a minor role, as different materials such as beta-
tricalciumphosphate,14 hyaluronic acid, and atelocollagen10
or a combination of hydroxyapatite and beta-tricalcium
phosphate showed comparable effects. Again, there were no
general beneficial effects, when these different scaffolds were
used along with different cell types. Therefore, our study
underscores the limited value of adding cells to the construct
when treating a critical-sized osteochondral defect in the
weight-bearing area of the knee joint. The reasons for the
FIG. 6. (A–D) and Fig. 7: International Cartilage Repair Society Score (ICRS) microscopic (A), macroscopic (B), and overall
evaluation (C) revealed higher scores for groups treated with scaffolds alone and scaffolds seeded with stem cell concentrates
compared with empty defects (asterisk, p<0.01). The number of tartrate-resistant acid phosphatase (TRAP)-positive cells was
determinedwithin an area of 8·6mmaround the center of thedefect (D, defect outlinedby 8·6mmredbox,magnification 2.5·and
40· (center, enlargement of an osteoclast, pointed out by the arrow). Color images available online at www.liebertpub.com/tec
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often limited benefits of co-transplanted cells or of added
bioactive molecules such as core binding factor beta (CBFb),
transforming growth factor beta (TGFb), insulin-like growth
factor one (IGF1), or keratogenin (KGN) are not really
known, as the fate and the role of MSCs in the host organism
is not fully understood.42 It could be demonstrated that al-
logenic green fluorescence-labeled BMCC survive for ap-
proximately 11 weeks in mice, but the amount of new bone
formation synthesized by these cells was very limited.36,37
Transplanted cells usually face a hostile immune system,
they lack grown physiological connections with the host
tissues, and the supply with nutrition and other factors is
problematic. Moreover, the transplanted cells compete di-
rectly with mumerous host cell types that are recruited from
the organism for the healing process. From this point of
view, the benefit of transplanted cells mainly depends on the
regeneration capacity of the host organism, which itself is
dependent on parameters such as age or tissue-specific
properties. Therefore and with regard to osteochondral de-
fects, the most crucial point seems to be a sufficient porosity
with a pore size of more than 300 mm and a high inter-
connectivity that is beneficial for rapid cellular ingrowth.38,39
In a recent study by Boos et al.,35 BMCC were compared
with MSC cultured in-vitro and then transplanted in-vivo on a
porous tricalcium phosphate ceramic scaffold. The results
show that even though there is a clear deficit of MSC in a
FIG. 7. Higher magnifica-
tion (40 · ) of the interface of
the defect and the bordering
bone showing the distribu-
tion of TRAP-positive cells.
Color images available online
at www.liebertpub.com/tec
Table 1. Characteristics of the Bone Marrow Aspirates and Concentrates Obtained
Using the Marrowstim System
Aspiration
(mL)
Nucleated cells
(aspirate; 106/mL)
Nucleated cells
(peripheral blood; 106/mL)
Nucleated cells (bone
marrow; 106/mL)
Fibroblast colony-forming
units/106 nucleated cells)
20 13.0 – 2.2 8.8 – 2.0 10.7 – 2.6 46.0 – 11.0
Progenitors in
aspirate (103)
Progenitors in
concentrate (103)
Concentration
( - fold)
Volume of
concentrate (cm3)
Number of progenitors
implanted (103)
1.1 – 0.3 7.2 – 2.1 6.8 – 1.2 2.1 – 0.1 14.9 – 3.9
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bone marrow aspirate concentrate, there is no increasing
effect of isolating and proliferating MSC on the bone for-
mation and vascularization of the constructs.
The role of MSCs for the regeneration of cartilage is a
matter of debate: MSC play a key role during fracture heal-
ing,40 and a transition of MSC into chondrocytes can be
achieved both in-vitro41 and in-vivo.42 Small molecules such
as CBFb, TGFb, IGF1, KGN, and more have been identified
to trigger chondrocyte-specific gene expression in MSC and
to protect chondrocytes in-vitro.42
In-vitro, mechanical stimulation of MSC has improved
proteoglycan and collagen contents of engineered chondro-
spheres.43 In-vivo, Jiang et al. reported superior tensile
properties of tricalcium phosphate scaffolds seeded with
mature chondrocytes compared with empty scaffolds in a
similar animal model,9 but Im et al. found inferior mechanical
behavior of osteochondral reconstructions using autologous
chondrocytes compared with empty defects and with a bi-
phasic scaffold.10 Li et al.44 have compared 8· 105 seeded
chondrocytes or MSCs and empty defects 6 months after
implantation in a swine model and found the highest equi-
librium compressive stress of 1.5MPa in the regenerated
cartilage produced by the MSC-seeded constructs. One can
hypothesize that we would have found better mechanical
properties with MSCs after proliferation, at least at a longer
time interval.
The miniature pig was chosen for this study, because there
is ample evidence in the literature that 10mm deep defects
exceeding 5.4mm do not heal spontaneously in this model
for approximately 2 years.13 Even though in this study the
diameter of the defects was maximized to 7mm, there was a
large variation in the endogenous healing response. Even in
the empty or upside-down cylinder group, some defects
healed nearly completely after only 3 months. More complete
filling of the defects with less significant differences could be
expected for longer observation periods.14
This study has several limitations: A longer follow up of 1
year would have been desirable.13 Differences between the
groups were small and are likely to have become smaller
during further follow up.14 The group size of 5 is also small
but was estimated according to sampling size evaluation
before the investigation (Appendix Table A2). Further char-
acterization of the heterogenic constructs at the molecular
level creates difficulties due to the wide range of regenerate
quality within the defects. The value for the clinical transfer
of the data is limited due to the model limitations and the
fact that surrounding tissue is mostly less favorable in a
pathologic osteochondral defect.45 For future studies, de-
fined cell numbers with different cell phenotypes are of high
interest.
Conclusions
This study shows that filling of osteochondral defects
with a porous scaffold decreases the defect size compared
with an autologous spongious bone cylinder or if defects
are left empty. Additional transplantation of a stem cell
concentrate increases local bone synthesis without affecting
the mechanical performance or the histologic appearance
of the implant. Reconstruction of the subchondral bone
remains the key for successful reconstruction of os-
teochondral defects.
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Appendix
Appendix Table A1. International Cartilage Society
Macroscopic and Gross Histologic Evaluation System
Cartilage repair assessment Points
Degree of repairing the defect 4
Integration to the border zone 4
Macroscopic appearence 4
Total max. 12
Overall repair assessment
Grade I: normal 12
Grade II: nearly normal 11–8
Grad III: abnormal 7–4
Grade IV: severely abnormal 3–1
Total max. 12
Histologic assessment scale Score
Surface 3
Matrix 3
Cell distribution 3
Cell population viability 3
Subchondral bone 3
Cartilage mineralization (calcified cartilage) 3
Total max. 18
Appendix Table A2. Kappa Interpretation
< 0 Poor agreement
0.0–0.20 Slight agreement
0.21–0.40 Fair agreement
0.41–0.60 Moderate agreement
0.61–0.80 Substantial agreement
0.81–1.00 Almost perfect agreement
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